Clover Health Investments CLOV Assumed Liability For Unpaid Claims And Claims Adjustment Expense
Assumed Liability For Unpaid Claims And Claims Adjustment Expense at other companies
Other financials
Where this comes from
Reported directly by Clover Health Investments in its filing.
Tagged under the XBRL concept us-gaap:AssumedLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense.
The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Clover Health Investments's assumed liability for unpaid claims and claims adjustment expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Clover Health Investments's assumed liability for unpaid claims and claims adjustment expense?
- Clover Health Investments (CLOV) reported assumed liability for unpaid claims and claims adjustment expense of $260.42M in Q1 2026.
- How has Clover Health Investments's assumed liability for unpaid claims and claims adjustment expense changed year-over-year?
- Clover Health Investments's assumed liability for unpaid claims and claims adjustment expense increased by 72.4% year-over-year, from $151.04M to $260.42M.
- What is the long-term trend for Clover Health Investments's assumed liability for unpaid claims and claims adjustment expense?
- Over 5 years (2020 to 2025), Clover Health Investments's assumed liability for unpaid claims and claims adjustment expense has grown at a 8.4% compound annual growth rate (CAGR), from $102.43M to $153.25M.
- What does assumed liability for unpaid claims and claims adjustment expense mean?
- This liability represents the total estimated cost for medical claims that have been incurred by policyholders but have not yet been reported or fully processed for payment. It includes both the anticipated claim amounts and the associated administrative costs required to settle these obligations. Monitoring this balance is essential for evaluating the adequacy of reserves and the company's long-term underwriting profitability.